DK478989A - 1,4-dihydropyridinderivat, fremgangsmaade til dets fremstilling og farmaceutiske midler indeholdende det - Google Patents

1,4-dihydropyridinderivat, fremgangsmaade til dets fremstilling og farmaceutiske midler indeholdende det Download PDF

Info

Publication number
DK478989A
DK478989A DK478989A DK478989A DK478989A DK 478989 A DK478989 A DK 478989A DK 478989 A DK478989 A DK 478989A DK 478989 A DK478989 A DK 478989A DK 478989 A DK478989 A DK 478989A
Authority
DK
Denmark
Prior art keywords
procedures
preparation
pharmaceutical agents
agents containing
dihydropyridine derivative
Prior art date
Application number
DK478989A
Other languages
Danish (da)
English (en)
Other versions
DK478989D0 (da
Inventor
Jean-Louis Peglion
Yves-Michel Gargouil
Jean-Paul Vilaine
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of DK478989D0 publication Critical patent/DK478989D0/da
Publication of DK478989A publication Critical patent/DK478989A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK478989A 1989-07-04 1989-09-28 1,4-dihydropyridinderivat, fremgangsmaade til dets fremstilling og farmaceutiske midler indeholdende det DK478989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8908920A FR2649395B1 (fr) 1989-07-04 1989-07-04 Nouveau derive de la dihydro-1,4 pyridine denomme (-) Ÿi1Ÿ(((amino-2 ethoxy)-2 ethoxy) methylŸi1Ÿ) -2 (dichloro-2,3 phenyl)-4 ethoxycarbonyl-3 methoxycarbonyl-5 methyl-6 dihydro-1,4 pyridine, son procede de preparation et les compositions qui le contiennent

Publications (2)

Publication Number Publication Date
DK478989D0 DK478989D0 (da) 1989-09-28
DK478989A true DK478989A (da) 1991-01-05

Family

ID=9383413

Family Applications (1)

Application Number Title Priority Date Filing Date
DK478989A DK478989A (da) 1989-07-04 1989-09-28 1,4-dihydropyridinderivat, fremgangsmaade til dets fremstilling og farmaceutiske midler indeholdende det

Country Status (14)

Country Link
EP (1) EP0406502B1 (de)
JP (1) JPH0720934B2 (de)
AT (1) ATE122340T1 (de)
AU (1) AU619049B2 (de)
CA (1) CA1327582C (de)
DE (1) DE68922605T2 (de)
DK (1) DK478989A (de)
ES (1) ES2074472T3 (de)
FR (1) FR2649395B1 (de)
IE (1) IE67059B1 (de)
NZ (1) NZ230854A (de)
OA (1) OA09136A (de)
PT (1) PT91869B (de)
ZA (1) ZA897349B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652083B1 (fr) * 1989-09-20 1992-01-24 Ador Cie Nouveau procede de separation d'isomeres optiques des derives de la dihydro-1,4 pyridine.
FR2686879B1 (fr) * 1992-02-05 1994-03-18 Adir Cie Nouveaux composes de 1,4-dihydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant.
DE4444864A1 (de) * 1994-12-16 1996-06-20 Bayer Ag Verwendung von 5-Acyl-1,4-dihydropyridinen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
FR2602231B1 (fr) * 1986-08-04 1988-10-28 Adir Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
AU619049B2 (en) 1992-01-16
AU4239089A (en) 1991-01-10
CA1327582C (fr) 1994-03-08
NZ230854A (en) 1991-02-26
JPH0720934B2 (ja) 1995-03-08
IE67059B1 (en) 1996-02-21
PT91869A (pt) 1991-03-20
IE893103A1 (en) 1991-01-16
ATE122340T1 (de) 1995-05-15
EP0406502A1 (de) 1991-01-09
EP0406502B1 (de) 1995-05-10
JPH0344371A (ja) 1991-02-26
ZA897349B (en) 1990-09-26
PT91869B (pt) 1995-07-18
DK478989D0 (da) 1989-09-28
FR2649395B1 (fr) 1992-11-06
DE68922605D1 (de) 1995-06-14
DE68922605T2 (de) 1996-01-04
OA09136A (fr) 1991-10-31
ES2074472T3 (es) 1995-09-16
FR2649395A1 (fr) 1991-01-11

Similar Documents

Publication Publication Date Title
NO891698L (no) Pyridonkarboksylsyrederivater og fremgangsmaate for deres fremstilling.
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
PT102145A (pt) Derivados de piperazina acetamida, processo para a sua preparacao e composicoes farmaceuticas.
ES2056860T3 (es) Derivados de n-((2-oxopirrolidin-1-il)-acetil)piperazina y medicamento contra la demencia senil.
MX9200777A (es) 4-[(2-benzotiazolil)metilamino]-alfa-[(3,4-difluorofenoxi)metil]-1-pip eridetanol.
DK478989A (da) 1,4-dihydropyridinderivat, fremgangsmaade til dets fremstilling og farmaceutiske midler indeholdende det
DK0421297T3 (da) Injicerbare præparater indeholdende cephalosporin som lægemiddel og anvendelse deraf
EP0535250A4 (en) Novel compounds and use thereof as medicine
NO985202D0 (no) Anti-heliobacter pylori-preparater inneholdende 1-metylcarbapenemderivater
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral
ATE154243T1 (de) Hemmstoff der blutgefässhypertrophie

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment